Home/Filings/4/0001209191-24-003921
4//SEC Filing

Elliott Jeffrey Thomas 4

Accession 0001209191-24-003921

CIK 0001124140other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 8:01 PM ET

Size

7.8 KB

Accession

0001209191-24-003921

Insider Transaction Report

Form 4
Period: 2024-02-21
Elliott Jeffrey Thomas
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2024-02-22$59.78/sh1,351$80,7635,063 total
  • Award

    Common Stock

    2024-02-21+2,7116,414 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,585
Footnotes (3)
  • [F1]Represents shares of common stock received upon settlement of a performance share unit award on February 21, 2024.
  • [F2]Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.
  • [F3]In addition to the shares of Common Stock reported on this Form 4, which total 6,648 shares, Mr. Elliott also holds, in the aggregate, an additional 140,678 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

Issuer

EXACT SCIENCES CORP

CIK 0001124140

Entity typeother

Related Parties

1
  • filerCIK 0001689757

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:01 PM ET
Size
7.8 KB